Company Presentations
Spotlight Innovation
Company Presentations are an integral programming element at the BIO Investor Forum that allow companies to discuss their pipeline, R&D activities, and future goals to this exclusive audience. The conference features 13-minute presentations by over 150 biotech companies poised to join the growth “watch list”, as well as a number of nonprofit and venture philanthropy organizations. The typical audience for all presentations features public and private equity investors, research analysts, investment bankers and industry executives.
Presenters benefit from a critical mass of decision-makers that you want to meet under one roof for two focused days, to tell your company’s story and attract the partners you need to succeed in developing innovations to help patients. Company presenters tend to receive double the number of BIO One-on-One Partnering™ requests than non-presenters, and schedule twice as many meetings than non-presenting companies. Presenting companies are also spotlighted in BIO’s marketing materials leading up to the event, as well as onsite.
Company presenters tend to receive double the number of requests than non-presenters, and schedule twice as many meetings than non-presenting companies. Presenting companies are also spotlighted in BIO's marketing materials leading up to the event, as well as onsite.
Companies and organizations present at the BIO Investor Forum to get in front of an exclusive audience of public and private equity investors, plus other biotech executives. (Since 2011, 44% of all US therapeutic IPO companies participated in a BIO Investor Forum event as a private company.)
Presenters are from early and established private companies, and emerging public companies. Companies must have a clear R&D focus, with a pipeline involving biotech therapeutics, diagnostics, or platform technologies, and can include patient advocacy groups.
